Critical interactions between TGF-β signaling/ELF, and E-cadherin/β-catenin mediated tumor suppression

Por Katuri, V, Tang, Y, Li, C, Jogunoori, W, Deng, C-X, Rashid, A, Sidawy, AN, Evans, S, Reddy, EP, Mishra, B, Mishra, L
Publicado em 2006

The STAT3 inhibitor NSC 74859 is effective in hepatocellular cancers with disrupted TGF-β signaling

Por Lin, L, Amin, R, Gallicano, GI, Glasgow, E, Jogunoori, W, Jessup, JM, Zasloff, M, Marshall, JL, Shetty, K, Johnson, L, Mishra, L, He, AR
Publicado em 2009

Disruption of transforming growth factor-β signaling through β-spectrin ELF leads to hepatocellular cancer through cyclin D1 activation

Por Kitisin, K, Ganesan, N, Tang, Y, Jogunoori, W, Volpe, EA, Kim, SS, Katuri, V, Kallakury, B, Pishvaian, M, Albanese, C, Mendelson, J, Zasloff, M, Rashid, A, Fishbein, T, Evans, SRT, Sidawy, A, Reddy, EP, Mishra, B, Johnson, LB, Shetty, K, Mishra, L
Publicado em 2007